Oseltamivir is the only effective treatment for influenza. A few uses we may not remember Review article
Article Sidebar
Published:
Nov 30, 2023
Keywords:
oseltamivir, influenza, pregnant, infants, prophylaxis
Main Article Content
Abstract
Oseltamivir, a neuraminidase inhibitor, is the only effective and safe drug against influenza A and B viruses. The use of oseltamivir that we should not forget about is: pregnant women or those planning to become pregnant, breastfeeding mothers, premature infants, caregivers of small infants, under 6 months of age and prophylactic use.
Article Details
How to Cite
Sybilski , A. J. (2023). Oseltamivir is the only effective treatment for influenza. A few uses we may not remember. Medycyna Faktow (J EBM), 16(3(60), 302-304. https://doi.org/10.24292/01.MF.0323.03
Issue
Section
Articles
Copyright © by Medical Education. All rights reserved.
References
1. Malosh RE, Martin ET, Heikkinen T et al. Efficacy and safety of oseltamivir in children: systematic review and individual patient data meta-analysis of randomized controlled trials. Clin Infect Dis. 2018; 66(10): 1492-500.
2. Doniec Z, Mastalerz-Migas A, Jackowska T et al. Rekomendacje postępowania w grypie u dzieci dla lekarzy Podstawowej Opieki Zdrowotnej. Fam Med Prim Care Rev. 2019; 21(2): 1-10.
3. AAP Committee on Infectious Diseases. Recommendations for Prevention and Control of Influenza in Children, 2022–2023. Pediatrics. 2022; 150(4): e2022059275.
4. Chow EJ, Beigi RH, Riley LE et al. Clinical Effectiveness and Safety of Antivirals for Influenza in Pregnancy. Open Forum Infect Dis. 2021; 8(6): ofab138.
5. Jones JC, Yen HL, Adams P et al. Influenza antivirals and their role in pandemic preparedness. Antiviral Res. 2023; 210: 105499.
2. Doniec Z, Mastalerz-Migas A, Jackowska T et al. Rekomendacje postępowania w grypie u dzieci dla lekarzy Podstawowej Opieki Zdrowotnej. Fam Med Prim Care Rev. 2019; 21(2): 1-10.
3. AAP Committee on Infectious Diseases. Recommendations for Prevention and Control of Influenza in Children, 2022–2023. Pediatrics. 2022; 150(4): e2022059275.
4. Chow EJ, Beigi RH, Riley LE et al. Clinical Effectiveness and Safety of Antivirals for Influenza in Pregnancy. Open Forum Infect Dis. 2021; 8(6): ofab138.
5. Jones JC, Yen HL, Adams P et al. Influenza antivirals and their role in pandemic preparedness. Antiviral Res. 2023; 210: 105499.